Flow Eighteen38 is to facilitate and accelerate antibody projects by delivering purified proteins.
Flow Eighteen38 has raised $5.4M in total funding. The most recent round was Corporate Round. The last funding was announced in March 2022.
Flow Eighteen38's investors include Fairjourney Biologics.
Flow Eighteen38 is headquartered in Porto, Portugal.
Flow Eighteen38 is to facilitate and accelerate antibody projects by delivering purified proteins.
Flow Eighteen38 is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Flow Eighteen38 — Funding & Investors." VCBacked, March 8, 2022, https://www.vcbacked.co/company/flow-eighteen38. Accessed September 30, 2026.
VCBacked. (2022). Flow Eighteen38 — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/flow-eighteen38
{{cite web |title=Flow Eighteen38 — Funding & Investors |url=https://www.vcbacked.co/company/flow-eighteen38 |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated